Insider Holders & Insider Ownership - Dyne Therapeutics Inc. (DYN)

List of insiders holdings for Dyne Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1RA CAPITAL MANAGEMENT L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner
2025-05-15 16:56:029,714,392
0
9,714,392Form 13G
2Atlas Venture Fund XI L.P.
Atlas Venture Associates XI L.P.
Atlas Venture Associates XI LLC
Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates Opportunity I LLC
Atlas Venture Opportunity Fund II L.P.
Atlas Venture Associates Opportunity II LP
Atlas Venture Associates Opportunity II LLC
10% Owner
2024-11-14 16:32:405,714,057
0
5,714,057Form 13G
3Forbion Capital Fund IV Cooperatief U.A.
10% Owner
2025-05-15 08:46:565,400,545
0
5,400,545Form 13G
4MPM BIOVENTURES 2018 L.P.
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
EVNIN LUKE
Foley Todd
GADICKE ANSBERT
10% Owner
2024-02-12 16:06:323,451,303
0
3,451,303Form 13G
5Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates Opportunity I LLC
Atlas Venture Opportunity Fund II L.P.
Atlas Venture Associates Opportunity II LP
Atlas Venture Associates Opportunity II LLC
10% Owner
2024-03-05 17:07:001,458,691
847,388
2,306,079Form 4
6VV Manager II LLC
Vida Ventures II LLC
VIDA VENTURES II-A LLC
10% Owner
2023-02-10 16:31:312,220,034
0
2,220,034Form 13D
7Logos Global Management LP
10% Owner
2023-02-14 15:53:472,150,000
0
2,150,000Form 13G
8Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
2020-09-23 18:56:451,608,785
0
1,608,785Form 4
9Brumm Joshua T
CEO & President
2024-03-12 21:56:20754,536
0
754,536Form 4
10Subramanian Romesh
Chief Scientific Officer
10% Owner
2020-09-18 17:12:38694,434
0
694,434Form 4
11CureDuchenne Ventures LLC
10% Owner
2020-09-23 19:05:52602,972
0
602,972Form 4
12Lucera Erick
Chief Financial Officer
2025-04-01 16:33:30280,600
0
280,600Form 4
13Beskrovnaya Oxana
Chief Scientific Officer
2025-03-13 16:08:14195,840
0
195,840Form 4
14Cox John
CEO & President
2025-06-06 16:07:07142,179
32,000
174,179Form 4
15Farwell Wildon
Chief Medical Officer
2024-08-20 16:27:16143,222
0
143,222Form 4
16McNeill Jonathan
Chief Business Officer
2024-08-20 16:27:39132,106
0
132,106Form 4
17HIGH SUSANNA GATTI
Chief Operating Officer
2024-09-19 16:52:28131,636
0
131,636Form 4
18Scalzo Richard William
SVP, Head of Finance & Admin.
2025-03-13 16:08:57122,330
0
122,330Form 4
19Friedl-Naderer Johanna
Chief Commercial Officer
2025-06-06 16:03:0495,911
0
95,911Form 4
20Kerr Douglas
Chief Medical Officer
2025-06-06 16:05:1892,815
0
92,815Form 4
21Stehman-Breen Catherine
Director
2025-06-03 21:37:2035,000
0
35,000Form 4
22Incerti Carlo
Director
2025-06-03 21:38:0535,000
0
35,000Form 4
23Kersten Dirk
Director
2025-06-03 21:38:4335,000
0
35,000Form 4
24Rhodes Jason P
Director
2025-06-03 21:39:2435,000
0
35,000Form 4
25Lubner David Charles
Director
2025-06-03 21:40:3535,000
0
35,000Form 4
26HURWITZ EDWARD
Director
2025-06-03 21:41:1035,000
0
35,000Form 4
27Klein Lawrence Otto
Director
2022-07-06 18:20:167,222
0
7,222Form 4